US Bancorp DE Sells 369 Shares of HealthSouth Corporation (NYSE:HLS)
US Bancorp DE cut its stake in shares of HealthSouth Corporation (NYSE:HLS) by 2.1% during the second quarter, Holdings Channel reports. The fund owned 17,424 shares of the company’s stock after selling 369 shares during the period. US Bancorp DE’s holdings in HealthSouth Corporation were worth $844,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Mesirow Financial Investment Management Equity Management increased its stake in HealthSouth Corporation by 15.1% in the first quarter. Mesirow Financial Investment Management Equity Management now owns 39,405 shares of the company’s stock valued at $1,687,000 after buying an additional 5,155 shares during the last quarter. Profund Advisors LLC increased its stake in HealthSouth Corporation by 2.8% in the first quarter. Profund Advisors LLC now owns 16,899 shares of the company’s stock valued at $723,000 after buying an additional 463 shares during the last quarter. Personal Capital Advisors Corp increased its stake in HealthSouth Corporation by 2.2% in the first quarter. Personal Capital Advisors Corp now owns 341,954 shares of the company’s stock valued at $14,523,000 after buying an additional 7,313 shares during the last quarter. Nationwide Fund Advisors increased its stake in HealthSouth Corporation by 2.7% in the first quarter. Nationwide Fund Advisors now owns 657,564 shares of the company’s stock valued at $28,150,000 after buying an additional 16,991 shares during the last quarter. Finally, State of Alaska Department of Revenue purchased a new stake in HealthSouth Corporation during the first quarter valued at $235,000. Hedge funds and other institutional investors own 97.96% of the company’s stock.
HealthSouth Corporation (HLS) traded up 0.53% during trading on Friday, reaching $43.82. The company’s stock had a trading volume of 2,206,221 shares. The stock has a market capitalization of $4.33 billion, a PE ratio of 15.97 and a beta of 0.61. The stock has a 50 day moving average price of $45.57 and a 200 day moving average price of $44.19. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71.
HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.68 by $0.03. The company had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. HealthSouth Corporation’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.69 EPS. Analysts anticipate that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be given a $0.25 dividend. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.00 dividend on an annualized basis and a yield of 2.28%. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s dividend payout ratio (DPR) is currently 35.29%.
Several equities analysts have issued reports on HLS shares. Zacks Investment Research upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research note on Thursday, June 29th. Royal Bank Of Canada reiterated a “buy” rating and issued a $53.00 target price on shares of HealthSouth Corporation in a research note on Wednesday, July 5th. KeyCorp started coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They issued a “sector weight” rating on the stock. Mizuho lifted their target price on HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a research note on Monday, July 10th. Finally, BidaskClub upgraded HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $48.83.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by company insiders.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.